A Proton Therapy Symposium held at the Dubai Department of Medical Education, and sponsored by SAH Global, gathered experts from around the world to discuss the clinical effectiveness of Proton Therapy in cancer treatments. World renowned physicians and innovators in cancer treatments gathered to discuss clinical advances and share knowledge in order to improve patient outcomes.
The symposium was led by two of the world’s leading oncologists, Allan Thornton, MD and Andrew Chang, MD. Dr. Thornton is a Chief Medical Officer and considered to be one the world’s best cancer physicians. He is regarded as a global leader in the research and development of Proton Therapy, and is sought after for his expertise in highly complex clinical cancer cases. Dr. Chang is a Consulting Director of pediatric radiation oncology, and one of only 5 pediatric Proton Therapy radiation oncologists in the United States. He is one of the world’s early adopters in Proton Therapy, having trained at the first clinical proton radiation therapy center in the world at Loma Linda University Medical Center.
Conversations at the symposium included detailed discussions of two important treatment pathways:
- Incorporating the appropriate sequence of chemotherapy/surgical/radiological intervention for solid tumors into patients’ Proton Therapy plans in order to improve outcomes.
- The assessment and treatment of solid tumors and other malignant diagnoses using novel targeted therapies and proton beam therapy for better patient outcomes and reduction of normal tissue damage.
Participants in the symposium included oncologist/hematologists, medical directors, nuclear medicine specialists, nurses, pediatric care providers, case managers and social workers. Together they participated in discussions that featured the clinical effectiveness of Proton Therapy versus alternative external beam radiotherapeutic approaches, proton applications for a variety of solid and lymphoid tumors and various diagnoses, including those relevant to the pediatric population.
SAH Global presents these symposiums with the goal of sharing advanced cancer treatment knowledge within the worldwide clinical community. It is hoped that increased use of these methodologies will reduce the incidence of cancer and improve patient outcomes across the globe.